- Global Pharma News & Resources

Anti-Snoring Treatment Market by Technology Advancement, Growth and Forecasts 2028

“Global Anti-Snoring Treatment Market Analysis Trends, Applications, Analysis, Growth, and Forecast to 2027” is a recent report generated by The global anti-snoring treatment market report has been segmented on the basis of device, surgical procedure, and region.

To get more insights, visit:

Snoring is noisy breathing during sleep that happens when the tissues shakes in the upper airway tract of humans. Some major cause of snoring includes smoke, drink too much alcohol, smoke, drink too much alcohol, sleep on your back, and overweight. Snoring can be a minor disorder, or can be sign of a dangerous medical condition. It is most common problem affecting people of all ages and both genders. For the proper treatment of snoring, it is very important to examine the pharynx, nasal cavity, and larynx, as well as to hear the snoring sound by using a tape recorder.

Key factor expected to drive the growth of the target market is increasing number of people suffering from snoring while sleeping. This can be due to growing number of obese people population, rising consumption of alcohol worldwide, and changing lifestyle. According to WHO, most of the world’s population are living in various countries are overweight and obesity and kills more people than underweight every year. In 2016, approximately 1.9 billion adults (18 years and older) were overweight and obese.

In addition, increasing geriatric, growing cigarette consumption and development of new medical advent products are other factors boosting the demand for anti-snoring products and treatment.

However, high cost and sometimes faulty product which led to recall of products are the factors hampering the growth of the target market over the forecast period.

On the basis of device, nasal devices segment is estimated to register significantly high market share over next ten years. This can be due to, nasal devices include nasal strips, nasal clips, etc. which are cost effective as compared to other treatment procedures. On the basis of surgical procedure, Uvulopalatopharyngoplasty (UPPP) has a decent success rate and is estimated to dominate the market. Various studies have proven that UPP surgical procedure has success rate over 50%.

The major players are focusing on receiving regulatory authority clearance for snoring devices in order to expand their market share. For instance, in February 2018, The Center for Craniofacial & Dental Sleep Medicine (CFDSM) received Food and Drug Administration(FDA) – clearance for snoring appliance and obstructive sleep apnea (OSA).

Currently, the markets in Asia Pacific is expected to register high growth and maintain its growth over the forecast period. This is primarily attributed to, improved healthcare infrastructure, growing number of private hospitals and home care center, increasing obese population especially in Thailand, Malaysia, and South Korea. In addition, the countries in Asia Pacific region have many pharmaceutical and biotechnology companies with research facilities and is expected to create a major opportunity for the player in the global anti-snoring market over the forecast period.

Key players

  • AccuMED Corp.

  • Apnea Sciences Corporation

  • Fisher & Paykel Healthcare Limited

  • Koninklijke Philips NV

  • GlaxoSmithKline, plc

  • ResMed, Inc.

  • AccuMED Corp.

  • Theravent, Inc.

  • Tomed GmbH, Whole You Inc.

  • The Pure Sleep Company

For sample copy of the report, please click:

In conclusion, the report disclose how this research could be a good guidance for the present and forecast market players. It broadcasts a thorough study of market to anticipate impending scope widening to the industry. Scrutinizing this report can act as a platform for users who intent to grasp each and every single opportunity of the industry.

Editor Details

Last Updated: 28-Feb-2019